|
Catalog Number 94731RX |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Vascular System (Circulation), Impaired (2572)
|
Event Date 05/11/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
A review of the device history record has been completed.
No deviations or non-conformances noted.
The event of is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.
Further information from the reporter regarding event, product, or patient details has been requested.
No additional information is available at this time.
This is a known potential adverse event addressed in the product labeling.
|
|
Event Description
|
Healthcare professional (hcp) reported vascular occlusion on the lips during injection in the lips with juvéderm® volbella¿ with lidocaine.
The hcp calmed the patient ¿from the problem caused on the lip¿.
On the same day, patient was treated with hyaluronidase and corticosteroids.
Patient was given nifedipine and acetylsalicylic acid to take home.
Patient was also given cicaplast® ¿because it regressed the edema and dried the lip, and there is the bruise¿.
¿patient is sacred if [they] will get better.
¿ 7 days later the patient was ¿better and calmer¿.
There was still ¿livedo¿ present.
The symptoms have not resolved.
|
|
Search Alerts/Recalls
|
|
|